USD
+$0.00
(+0.00%
)At Close (As of Sep 8, 2025)
$44.74B
Market Cap
56.16
P/E Ratio
4.86
EPS
$296.72
52 Week High
$200.30
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | $2B |
Total Revenue | $2.7B |
Cost Of Revenue | $700M |
Costof Goods And Services Sold | $700M |
Operating Income | $691M |
Selling General And Administrative | $266M |
Research And Development | $693M |
Operating Expenses | $1.4B |
Investment Income Net | - |
Net Interest Income | $208M |
Interest Income | $208M |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $39M |
Income Before Tax | $919M |
Income Tax Expense | $205M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | $714M |
Comprehensive Income Net Of Tax | - |
Ebit | $691M |
Ebitda | $731M |
Net Income | $714M |
Field | Value (USD) |
---|---|
Total Assets | $7.3B |
Total Current Assets | $6.3B |
Cash And Cash Equivalents At Carrying Value | $1.1B |
Cash And Short Term Investments | $1.1B |
Inventory | - |
Current Net Receivables | $1.1B |
Total Non Current Assets | $1B |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | $44M |
Intangible Assets Excluding Goodwill | $44M |
Goodwill | $440M |
Investments | - |
Long Term Investments | - |
Short Term Investments | $4B |
Other Current Assets | $101M |
Other Non Current Assets | - |
Total Liabilities | $1.5B |
Total Current Liabilities | $1.4B |
Current Accounts Payable | $30M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $20M |
Total Non Current Liabilities | $109M |
Capital Lease Obligations | $76M |
Long Term Debt | - |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $76M |
Other Current Liabilities | $65M |
Other Non Current Liabilities | $43M |
Total Shareholder Equity | $5.8B |
Treasury Stock | - |
Retained Earnings | $3.5B |
Common Stock | $2K |
Common Stock Shares Outstanding | $165M |
Field | Value (USD) |
---|---|
Operating Cashflow | $1.1B |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $51M |
Capital Expenditures | $21M |
Change In Receivables | - |
Change In Inventory | - |
Profit Loss | - |
Cashflow From Investment | -$700M |
Cashflow From Financing | $26M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | $714M |
Field | Value (USD) |
---|---|
Gross Profit | $2B |
Total Revenue | $2.7B |
Cost Of Revenue | $700M |
Costof Goods And Services Sold | $700M |
Operating Income | $691M |
Selling General And Administrative | $266M |
Research And Development | $693M |
Operating Expenses | $1.4B |
Investment Income Net | - |
Net Interest Income | $208M |
Interest Income | $208M |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $39M |
Income Before Tax | $919M |
Income Tax Expense | $205M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | $714M |
Comprehensive Income Net Of Tax | - |
Ebit | $691M |
Ebitda | $731M |
Net Income | $714M |
Sector: HEALTHCARE
Industry: HEALTH INFORMATION SERVICES
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, Asia Pacific, the Middle East, Africa, and Latin America. The company is headquartered in Pleasanton, California.